Feto-Maternal Outcome In Pregnancy Complicated By Oligohydramnios: A Prospective Observational Study

Authors

  • Archana Patel
  • Savan M. Chauhan
  • Rushikumar A. Kaneria
  • Mona N. Shah

DOI:

https://doi.org/10.52783/jns.v14.2499

Keywords:

Cryotherapy, topical anesthetic, Pain Perception, Visual Analogue Scale and Dibucaine

Abstract

Introduction: Amniotic fluid plays a critical role in fetal development, providing protection, facilitating movement, and supporting respiratory functions. Oligohydramnios, defined as an amniotic fluid index (AFI) ≤5 cm, is associated with increased perinatal risks, including umbilical cord compression and impaired fetal circulation. This study aims to evaluate maternal and fetal outcomes associated with oligohydramnios in a tertiary care setting.

Materials and Methodology: A prospective, observational hospital-based study was conducted over 1.5 years in the Obstetrics and Gynecology Department at a tertiary care hospital in Gujarat. A total of 163 pregnant women with singleton pregnancies between 28-42 weeks gestation and intact membranes were enrolled. Detailed demographic, clinical, and ultrasonographic assessments were performed. Maternal parameters such as parity, gestational age, and associated conditions were recorded. Neonatal outcomes, including birth weight, APGAR scores, NICU admissions, and perinatal mortality, were analyzed. Statistical analysis was performed using rates, proportions, and percentages.

Results: Most participants (80.98%) were aged 21-30 years, with 50.30% delivering preterm. PIH (22.7%) and idiopathic factors (41.1%) were the most common causes of oligohydramnios. LSCS was performed in 46.62% of cases. NICU admission was required for 69.94% of neonates, primarily due to preterm birth (29.82%) and low birth weight (16.81%). APGAR scores >7 were observed in 92.64% of neonates. Perinatal mortality was 1.59%.

Conclusion: Oligohydramnios is significantly associated with increased rates of preterm birth, LSCS, and NICU admissions. Early diagnosis and fetal surveillance are crucial in optimizing perinatal outcomes and reducing neonatal complications.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al. Amniotic fluid. Williams Obstetrics. 24th ed. New York: McGraw-Hill Education; 2014. p. 231.

Magann EF, Chauhan SP, Bofill JA, Martin JN. Comparability of the amniotic fluid index and single deepest pocket measurements in clinical practice. Aust New Zeal J Obstet Gynaecol. 2003; 43(1): 75-7.

Kofinas A, Kofinas G. Differences in amniotic fluid patterns and fetal biometric parameters in third trimester pregnancies with and without diabetes. J Matern Neonatal Med. 2006;19(10):633-8.

Entezami M, Albig M, Gasiorek-Wiens A, Becker R. Placenta, cord and amniotic fluid (Chapter 14) In: Ultrasound diagnosis of fetal anomalies. Edition III US: Thieme Medical Pub; 2003: 301.

Konar H. D C Dutta’s Textbook of obstetrics.2015;8:250-251.

Manning FA, Hill LM, Platt LD. Qualitative amniotic fluid volume determination by ultrasound: Ante partum detection of intrauterine growth retardation. Am J Obstet Gynecol. 1981;139:254-8.

Manning FA, Harman CR, Morrison I, Menticoglou SM, Lange IR, Johnson JM. Fetal assessment based on fetal biophysical profile scoring. IV. An analysis of perinatal morbidity and mortality. Am J Obstet Gynecol. 1990;162(3):703-9.

Phelan JP, Smith CV, Small M. Amniotic fluid volume assessment with the four-quadrant technique at 36 to 42 weeks gestation. J Reprod Med. 1987;32:540-2.

Brace RA. Physiology of amniotic fluid volume regulation. Clin Obstet Gynecol. 1997;40:280-9.

Locatelli A, Zagarella A, Toso L, Assi F, Ghidini A, Biffi A. Serial assessment of amniotic fluid index in uncomplicated term pregnancies: prognostic value of amniotic fluid reduction. J Matern Neonatal Med. 2004;15:233-6.

Biradar KD, Shamanewadi AN. Maternal and perinatal outcome in oligohydramnios: study from a tertiary care hospital, Bangalore, Karnataka, India. Int J Reprod Contracept Obstet Gynecol, 2016;5(7):2291-9.

Lester Figueroa et al. Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low- middle income countries. Reproductive Health volume. 2020;17:19.

Moses V, Thakre S. A study of maternal and fetal outcome in third trimester diagnose case of oligohydramnios. Int J Reprod Contracept Obstet Gynecol 2016;5:2944-8.

Modi JY, Patel RV, Shah PT, Agrawal AG. Fetomaternal outcome in pregnancy with oligohydramnios. Int J Reprod Contracept Obstet Gynecol 2016;5:4037-40.

Chauhan SP, Hendrix NW: Intrapartum oligohydramnios does not predict adverse peripartum outcome among high risk parturients Am J Obstet Gynecol. 1997;176(6):1130-6.

Magann EF, Mortan ML, Nolan TE Martin JN, Whitworth NS, Morrison JC. Comparative efficacy of sonographic measurements for the detection of aberrations in the amniotic fluid volume on pregnancy outcome. Obstet Gynecol. 1994;83:959-62.

Carroll BC, Bruner JP. Umbilical artery Doppler velocimetry in pregnancies complicated by oligohydramnios. J Repord. Med. 2000;45:562-6.

Casey BM. Pregnancy outcome after antepartum diagnosis of oligohydramnios at or beyond 34 weeks gestation. Am J Obstet Gynaecol. 2000;182:909-12.

Golan G. Oligohydramnios-maternal complication and fetal outcome in 145 cases. Gynecol Obstet Invest. 1994;37(2):91-5.

Sriya R, Singhai S. Perinatal outcome in patients with amniotic fluid index < 5cm. J Obstet Gynaecol India. 2001;51:98-100.

Casey BM, McIntire DD, Bloom SL, Lucas MJ, Santos R, Twickler DM, et al. Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks’ of gestation. Am J Obstet Gynecol 2000;182(4):909-12.

Jun Z, Troendle J. Isolated oligohydramnios is not associated with adverse perinatal outcome. British J Obst Gynae. 2004;111(3):220-5.

Chandra P, Kaur SP, Hans DK. The impact of amniotic fluid volume assessed intra partum on perinatal outcome. Obstet and Gynecol Today. 2000; 5(8); 478-81.

Chate P, Khatri M, Hariharan C. Pregnancy outcome after diagnosis of oligohydramnios at term. Int J Reprod Contracept Obstet Gynecol. 2013; 2: 23-26.

Chhabra S, Dargan R. Oligohydramnios - a potential marker for serious obstetric complications. J Obstet Gynecol. 2007;27(7):680-3.

Wolff F, Schaefer R. Oligohydramnios-perinatal complications and diseases in mother and child. Geburtshilfe Frauenheilkd Mar. 1994;54(3):139-43.

Sarid AL, Levy A. Placental pathologies associated with fetal groth restriction associated with or without oligohydramnios. Arcy Gynecol Obstet. 2009;280(4):549-52.

Downloads

Published

2025-03-23

How to Cite

1.
Patel A, Chauhan SM, A. Kaneria R, N. Shah M. Feto-Maternal Outcome In Pregnancy Complicated By Oligohydramnios: A Prospective Observational Study. J Neonatal Surg [Internet]. 2025Mar.23 [cited 2025Oct.11];14(8S):88-94. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/2499